HFM
RPRX icon

Harvest Fund Management’s Royalty Pharma RPRX Stock Holding History

Harvest Fund Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-148
Closed -$7K – 541
2026
Q1 		$7K Hold
148
– – ﹤0.01% 454
2025
Q4 		$6K Hold
148
– – ﹤0.01% 528
2025
Q3 		$5K Hold
148
– – ﹤0.01% 568
2025
Q2 		$5K Hold
148
– – ﹤0.01% 557
2025
Q1 		$5K Buy
+148
New +$4.69K ﹤0.01% 615

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Fund Management's RPRX Position: Q2 2026 in Review

Harvest Fund Management sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 148 shares — an estimated $7K sold.

Harvest Fund Management first reported a position in RPRX in Q1 2025 and held it in 5 quarters. The position peaked at $7K in Q1 2026. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Harvest Fund Management reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • Harvest Fund Management sold 148 Royalty Pharma shares in Q2 2026, an estimated $7K.
  • Harvest Fund Management first reported a position in Royalty Pharma in Q1 2025 and held it in 5 quarters.
  • Harvest Fund Management's Royalty Pharma position peaked at $7K in Q1 2026.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.